Gut motility and transit changes in patients receiving long-term methadone maintenance

Journal of Clinical Pharmacology

Volumn 38, Issue 10, 1998, Pages 931-935

  Yuan, Chun Su ^a   Foss, Joseph F ^a   O'Connor, Michael ^a   Moss, Jonathan ^a   Roizen, Michael F ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN; ILLICIT DRUG; LACTULOSE; METHADONE; OPIATE; OPIATE ANTAGONIST;

ADULT; ARTICLE; CLINICAL ARTICLE; CONSTIPATION; DRUG DEPENDENCE; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HYDROGEN BREATH TEST; INTESTINE; INTESTINE MOTILITY; INTESTINE TRANSIT TIME; MALE; ORAL DRUG ADMINISTRATION;

EID: 0031727649     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1998.tb04389.x     Document Type: Article

References (19)

1. Walsh TD: Oral morphine in chronic cancer pain. Pain 1984; 18:1-11.
2. Glare P, Lickiss JN: Unrecognized constipation in patients with advanced cancer: a recipe for therapeutic disaster. J Pain Symptom Manage 1992;7:369-371.
3. Jaffe JH, Martin WR: Opioid analgesics and antagonists. In, Gilman AF, Rall TW, Nies AS, Taylor P (eds.): The Pharmacological Basis of Therapeutics. Eighth edition. New York: Pergamon Press, 1990;485-521.
4. Green AF: Comparative effects of analgesics on pain threshold, respiratory frequency, and gastrointestinal propulsion. Br J Pharmacol 1959;14:26-34,
5. Niemegeers C, Lenaerts F, Awouters F: Preclinical animal studies of modern antidiarrheals: in vivo pharmacology. In, Van Bever W, Lal H (eds.): Synthetic Antidiarrheal Drugs: Synthesis-Preclinical and Clinical Pharmacology. New York: Marcel Deckker, 1976; 65-114.
6. 2) measurements. J Lab Clin Med 1975;85:546-555.
7. Basilisco G, Bozzani A, Camboni G, Recchia M, Quatrini M, Conte D, et al: Effects of loperamide and naloxone on mouth-tocaecum transit time evaluated by lactulose hydrogen breath test. Gut 1985;26:700-703.
8. Basilisco G, Camboni G, Bozzani A, Paravicini M, Bianchi PA: Oral naloxone antagonizes loperamide-induced delay of orocecal transit. Dig Dis Sci 1987;32:829-832.
9. Bond JH, Levitt MD: Use of breath hydrogen (H2) in the study of carbohydrate absorption. Am J Dig Dis 1977;22:379-382.
10. Read NW, Al-Janabi MN, Bates TE, Holgate AM, Cann PA, Kansman RI, et al: Interpretation of the breath hydrogen profile obtained after ingesting a solid meal containing unabsorbable carbohydrate. Gut 1985;26:834-842.
11. Yuan CS, Foss JF, O'Connor M, Toledano A, Roizen MF, Moss J: Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial. Clin Pharmacol Ther 1996;59: 469-475.
12. Yuan CS, Foss JF, Osinski J, Toledano A, Roizen MF, Moss J: The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time. Clin Pharmacol Ther 1997:61:467-475.
13. Gilat J, Ben Hur H, Gelman-Malachi E, Terdiman R, Peled Y: Alternations of the colonic flora and their effect on the hydrogen breath test. Gut 1978;19:602-605.
14. von der Ohe M, Camilleri M: Measurements of small bowel and colonic transit: indications and methods. Mayo Clin Proc 1992;67:1169-1179.
15. Thompson DG, Binfield P, De Belder A, O'Brien J, Warren S, Wilson M: Extra intestinal influences on exhaled breath hydrogen measurements during the investigation of gastrointestinal disease. Gut 1985;26:1349-1352.
16. Cheskin LJ, Chami TN, Johnson RE, Jaffe JH: Assessment of nalmefene glucuronide as a selective gut opioid antagonist. Drug Alcohol Dependence 1995;39:151-154.
17. Russel J, Bass P, Goldberg LI, Schuster CR, Merz H: Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists. Eur J Pharmacol 1982;79:255-261.
18. Brown DR, Goldberg LI: The use of quaternary narcotic antagonists in opiate research. Neuropharmacology 1985;24:181-191.
19. Foss JF, O'Connor M, Yuan CS, Murphy M, Moss J, Roizen MF: Safety and tolerance of methylnaltrexone in healthy humans: a randomized placebo-controlled intravenous ascending-dose and pharmacokinetic study. J Clin Pharmacol 1997;37:25-30.